Executive Committee

Executive Committee

David Bevan

CEO Vifor Fresenius Medical Care Renal Pharma Ltd. & Chief Marketing Officer

  • British citizen 
  • Leading positions such as Speciality Care Business Unit Director of Pfizer UK Ltd.  and Regional VP Commercial Operations of Otsuka Pharmaceutical Europe Ltd.
  • Joined the Vifor Pharma Group as CEO Vifor Fresenius Medical Care Renal Pharma Ltd. in 2017
  • Since 2018 CEO Vifor Fresenius Medical Care Renal Pharma & Chief Marketing Officer

Colin Bond

Chief Financial Officer

  • British and Swiss citizen
  • FCA, Institute of Chartered Accountants in England and Wales, MRPharmS, Royal Pharmaceutical Society of Great Britain, MBA, London Business School, BSc. in Pharmacy, University of Aston in Birmingham
  • Leading positions such as CFO of the listed biotechnology company Evotec, CFO of Jet Aviation Group, CFO (EMEA) for Ecolab and CFO of Novelis Europe. During his early career he worked as a pharmacist, auditor and management consultant for Procter & Gamble, Arthur Andersen and PricewaterhouseCoopers.
  • Since 2013 Board member, Chairman of the Audit Committee of Siegfried AG
  • Joined the company as CFO in 2016

Dario Eklund

Chief Commercial Officer

  • Finnish/Austrian citizen
  • Master in Science, Swedish School of Economics and Business Administration in Helsinki, Finland
  • Leading positions such as Commercial Director, Area Manager Eastern Europe & Israel and Country Manager with Novartis, Switzerland & USA, General Manager of Aventis Pharma AG (now Sanofi), Switzerland and Vice President for Non US Operations, Business Development and Gintuit Business Unit with Organogenesis Inc., USA
  • Joined the company as Head of Global Business Operations in 2014
  • Since May 2017 Chief Commercial Officer

Scott Garland

President Relypsa

  • USA citizen 
  • MBA, Duke University’s Fuqua School of Business, B.S. in Biological Sciences, California Polytechnic State University, San Luis Obispo
  • Leading positions such as Executive Vice President and Chief Commercial Officer of Exelixis, Vice President, Avastin Franchise, at Genentech 
  • Joined Relypsa as Chief Commercial Officer in 2014
  • President Relypsa and member of the Vifor Pharma Executive Committee since May 2017

Michael Puri

Chief HR Officer

  • Belgium citizen of Indian and Polish origins
  • Bilingual in English and French and conversational in Italian and Dutch
  • Bachelor (Hons.) in Economics & Master in Strategic Marketing, University of Nantes and ESG Management School of Grenoble, France
  • Started his professional life in Marketing but then moved to HR where he has since developed a multinational career over the last 15 years, working amongst others as Senior Director Global Talent Development for UCB and Vice President Human Resources Europe for Staples
  • Joined us from GrandVision where he served as the Global Head of the HR function and a member of the Global Executive Team
  • Since 2015 Senior Vice President & Chief HR Officer Vifor Pharma

Dr. Christoph Springer

Chief Strategy Officer

  • Swiss citizen
  • Master of Natural Science at the Swiss Federal Institute of Technology (ETH) Zurich, PhD in Molecular Biology at Georg-August-University, Göttingen, MBA studies at George Washington University, Washington DC
  • Global Product Leader Anaemia, with Vifor (International) Ltd., then General Manager and International Marketing Director Anaemia with AMGEN Switzerland AG
  • Joined the company in 2007 as Global Head of Anaemia TA Marketing
  • 2011 - 2016 Deputy CEO Vifor Fresenius Medical Care Renal Pharma Ltd.
  • 2016 - 2017 Head of Global Business Development of Vifor Pharma
  • Since 2018 Chief Strategy Officer

David Bevan

CEO Vifor Fresenius Medical Care Renal Pharma Ltd. & Chief Marketing Officer

  • British citizen 
  • Leading positions such as Speciality Care Business Unit Director of Pfizer UK Ltd.  and Regional VP Commercial Operations of Otsuka Pharmaceutical Europe Ltd.
  • Joined the Vifor Pharma Group as CEO Vifor Fresenius Medical Care Renal Pharma Ltd. in 2017
  • Since 2018 CEO Vifor Fresenius Medical Care Renal Pharma & Chief Marketing Officer

Colin Bond

Chief Financial Officer

  • British and Swiss citizen
  • FCA, Institute of Chartered Accountants in England and Wales, MRPharmS, Royal Pharmaceutical Society of Great Britain, MBA, London Business School, BSc. in Pharmacy, University of Aston in Birmingham
  • Leading positions such as CFO of the listed biotechnology company Evotec, CFO of Jet Aviation Group, CFO (EMEA) for Ecolab and CFO of Novelis Europe. During his early career he worked as a pharmacist, auditor and management consultant for Procter & Gamble, Arthur Andersen and PricewaterhouseCoopers.
  • Since 2013 Board member, Chairman of the Audit Committee of Siegfried AG
  • Joined the company as CFO in 2016

Dario Eklund

Chief Commercial Officer

  • Finnish/Austrian citizen
  • Master in Science, Swedish School of Economics and Business Administration in Helsinki, Finland
  • Leading positions such as Commercial Director, Area Manager Eastern Europe & Israel and Country Manager with Novartis, Switzerland & USA, General Manager of Aventis Pharma AG (now Sanofi), Switzerland and Vice President for Non US Operations, Business Development and Gintuit Business Unit with Organogenesis Inc., USA
  • Joined the company as Head of Global Business Operations in 2014
  • Since May 2017 Chief Commercial Officer

Scott Garland

President Relypsa

  • USA citizen 
  • MBA, Duke University’s Fuqua School of Business, B.S. in Biological Sciences, California Polytechnic State University, San Luis Obispo
  • Leading positions such as Executive Vice President and Chief Commercial Officer of Exelixis, Vice President, Avastin Franchise, at Genentech 
  • Joined Relypsa as Chief Commercial Officer in 2014
  • President Relypsa and member of the Vifor Pharma Executive Committee since May 2017

Michael Puri

Chief HR Officer

  • Belgium citizen of Indian and Polish origins
  • Bilingual in English and French and conversational in Italian and Dutch
  • Bachelor (Hons.) in Economics & Master in Strategic Marketing, University of Nantes and ESG Management School of Grenoble, France
  • Started his professional life in Marketing but then moved to HR where he has since developed a multinational career over the last 15 years, working amongst others as Senior Director Global Talent Development for UCB and Vice President Human Resources Europe for Staples
  • Joined us from GrandVision where he served as the Global Head of the HR function and a member of the Global Executive Team
  • Since 2015 Senior Vice President & Chief HR Officer Vifor Pharma

Dr. Christoph Springer

Chief Strategy Officer

  • Swiss citizen
  • Master of Natural Science at the Swiss Federal Institute of Technology (ETH) Zurich, PhD in Molecular Biology at Georg-August-University, Göttingen, MBA studies at George Washington University, Washington DC
  • Global Product Leader Anaemia, with Vifor (International) Ltd., then General Manager and International Marketing Director Anaemia with AMGEN Switzerland AG
  • Joined the company in 2007 as Global Head of Anaemia TA Marketing
  • 2011 - 2016 Deputy CEO Vifor Fresenius Medical Care Renal Pharma Ltd.
  • 2016 - 2017 Head of Global Business Development of Vifor Pharma
  • Since 2018 Chief Strategy Officer